Magnetar Financial’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.2M Buy
37,105
+30,118
+431% +$1.05M 0.01% 421
2026
Q2
$300K Buy
6,987
+590
+9% +$22K ﹤0.01% 787
2026
Q1
$257K Buy
+6,397
New +$276K ﹤0.01% 802
2025
Q2
– Sell
-16,982
Closed -$408K – 1164
2025
Q1
$408K Buy
+16,982
New +$546K 0.01% 504
2024
Q3
– Sell
-18,021
Closed -$652K – 703
2024
Q2
$652K Buy
+18,021
New +$715K 0.01% 312

Other funds holding VERA

Magnetar Financial's VERA Position: Q3 2026 in Review

Magnetar Financial increased its Vera Therapeutics (VERA) stake by 431% in Q3 2026, buying an estimated $1.05M and bringing the position to 37,105 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #421.

Magnetar Financial first reported a position in VERA in Q2 2024 and has held it in 5 quarters since. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Magnetar Financial held 37,105 shares of Vera Therapeutics worth $1.2M as of Q3 2026.
  • Magnetar Financial bought 30,118 Vera Therapeutics shares in Q3 2026, an estimated $1.05M.
  • Vera Therapeutics made up 0.01% of Magnetar Financial's portfolio in Q3 2026, its #421 holding.
  • Magnetar Financial first reported a position in Vera Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.